Bronchoscopy: Clinical Trials

11 trials of Bronchoscopy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 recruiting, 1 terminated. 11 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 9, Recruiting 1, Terminated 1
Phase 24Completed 4

Follow Bronchoscopy: new trials by email Literature Review of Bronchoscopy trials Research Report on Bronchoscopy

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock
Phase 1 / Phase 2CompletedKing Abdul Aziz Specialist Hospital2002020-07-022023-10-10
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock
Phase 1 / Phase 2CompletedKing Abdul Aziz Specialist Hospital2002020-07-022022-07-06
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock
Phase 1 / Phase 2CompletedKing Abdul Aziz Specialist Hospital2002020-07-022023-10-10
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)172017-07-032026-11-12
A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers
RO7033877 + Bronchoscopy - Healthy Volunteer
Phase 1CompletedHoffmann-La Roche322014-06-012016-11-02
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage, Phlebotomy - Asthma, Allergies
Phase 1CompletedAndrew D. Luster, M.D.,Ph.D.432013-01-012026-09-28
T Cell Effector and Regulatory Mechanisms in Asthma
Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging) - Asthma, Allergies
Phase 1CompletedAndrew D. Luster, M.D.,Ph.D.1682012-09-012017-09-15
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage - Asthma
Phase 1RecruitingBenjamin Medoff3132008-01-012026-11-06
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization - Lung Cancer, Precancerous Condition
Phase 1CompletedBritish Columbia Cancer Agency302007-01-012012-03-09
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
Prednisolone, Bronchoscopy - Asthma
Phase 1TerminatedGlaxoSmithKline472005-08-022017-08-04
Carbon Monoxide to Prevent Lung Inflammation
Bronchoscopy, Bronchoalveolar lavage, Endotoxin - Respiratory Distress Syndrome, Adult
Phase 1CompletedNational Institutes of Health Clinical Center (CC)352004-10-132019-12-17

Conditions studied

Asthma (4)  ·  Inflammation (3)  ·  Shock, Septic (3)  ·  Hypersensitivity (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Constriction, Pathologic (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, AIDS-Related (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Primary Effusion (1)  ·  Precancerous Conditions (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

King Abdul Aziz Specialist Hospital (3)  ·  Andrew D. Luster, M.D.,Ph.D. (2)  ·  Benjamin Medoff (1)  ·  British Columbia Cancer Agency (1)  ·  GlaxoSmithKline (1)  ·  Hoffmann-La Roche (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (6)  ·  Saudi Arabia (3)  ·  Canada (1)  ·  United Kingdom (1)

Top investigators

Andrew D Luster, M.D., Ph.D. (2)  ·  Anthony F Suffredini, M.D. (1)  ·  Benjamin D Medoff, MD, PhD (1)  ·  Ramya Ramaswami, MBBS, MPH (1)  ·  Stephen Lam, MD (1)

Results publications

PMID 24386300, PMID 29550052, PMID 35868533

NIH funding

U19AI095261 (2)